Locoregional delivery of chimeric antigen receptor-T cells: Breaking the spell in glioblastoma?
作者信息
Geurts Marjolein, Preusser Matthias
机构信息
The Brain Tumour Center at the Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Division of Oncology, Department of Medicine 1, Medical University, Vienna, Austria.
出版信息
Neuro Oncol. 2024 Jul 5;26(7):1177-1180. doi: 10.1093/neuonc/noae063.
Abstract
摘要
相似文献
1
Locoregional delivery of chimeric antigen receptor-T cells: Breaking the spell in glioblastoma?
Neuro Oncol. 2024 Jul 5;26(7):1177-1180. doi: 10.1093/neuonc/noae063.
2
Next-generation CAR T cell therapies for glioblastoma.
Sci Transl Med. 2024 Aug 28;16(762):eadp2660. doi: 10.1126/scitranslmed.adp2660.
3
Three recent breakthroughs in CAR T cells for the treatment of glioblastoma: Is it the light at the end of the tunnel?
Mol Ther. 2024 May 1;32(5):1187-1189. doi: 10.1016/j.ymthe.2024.04.018. Epub 2024 Apr 17.
4
CAR T cells offer hope in glioblastoma.
Nat Rev Neurol. 2024 Jun;20(6):315. doi: 10.1038/s41582-024-00972-w.
5
Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy.
CNS Drugs. 2020 Feb;34(2):127-145. doi: 10.1007/s40263-019-00687-3.
6
Intracranial CAR-T cell delivery in glioblastoma patients.
Trends Cancer. 2024 Jun;10(6):478-480. doi: 10.1016/j.trecan.2024.05.002. Epub 2024 May 22.
7
Chimeric Antigen Receptor T-Cell Therapy: Updates in Glioblastoma Treatment.
Neurosurgery. 2021 May 13;88(6):1056-1064. doi: 10.1093/neuros/nyaa584.
8
Infusion of CARv3-TEAM-E T Cells in Glioblastoma.
N Engl J Med. 2024 Jun 27;390(24):2330. doi: 10.1056/NEJMc2405721.
9
Armed hunter killers: discerning the role of adoptive T-cell transfer for glioblastoma.
Immunotherapy. 2015;7(5):481-5. doi: 10.2217/imt.15.22.
10
CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges.
Neuro Oncol. 2018 Oct 9;20(11):1429-1438. doi: 10.1093/neuonc/noy032.
引用本文的文献
1
A Review of Emerging Immunotherapeutic Strategies for IDH-Mutant Glioma.
Cancers (Basel). 2025 Jun 27;17(13):2178. doi: 10.3390/cancers17132178.
2
In Vitro Evaluation of Genetically Unmodified Ligand-Armed Allogeneic Natural Killer Cells to Treat EGFR-Positive Glioblastoma.
Cells. 2025 Feb 11;14(4):254. doi: 10.3390/cells14040254.
本文引用的文献
1
Advancements in chimeric antigen receptor-expressing T-cell therapy for glioblastoma multiforme: Literature review and future directions.
Neurooncol Adv. 2024 Feb 20;6(1):vdae025. doi: 10.1093/noajnl/vdae025. eCollection 2024 Jan-Dec.
2
Systemic and local immunosuppression in glioblastoma and its prognostic significance.
Front Immunol. 2024 Feb 28;15:1326753. doi: 10.3389/fimmu.2024.1326753. eCollection 2024.
3
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results.
Nat Med. 2024 May;30(5):1320-1329. doi: 10.1038/s41591-024-02893-z. Epub 2024 Mar 13.
4
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma.
N Engl J Med. 2024 Apr 11;390(14):1290-1298. doi: 10.1056/NEJMoa2314390. Epub 2024 Mar 13.
5
Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial.
Nat Med. 2024 Apr;30(4):1001-1012. doi: 10.1038/s41591-024-02875-1. Epub 2024 Mar 7.
6
A systematic review of immunotherapy in high-grade glioma: learning from the past to shape future perspectives.
Neurol Sci. 2024 Jun;45(6):2561-2578. doi: 10.1007/s10072-024-07350-w. Epub 2024 Feb 3.
7
Primary brain tumours in adults.
Lancet. 2023 Oct 28;402(10412):1564-1579. doi: 10.1016/S0140-6736(23)01054-1. Epub 2023 Sep 19.
8
Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors.
Mol Ther. 2022 Jul 6;30(7):2537-2553. doi: 10.1016/j.ymthe.2022.05.011. Epub 2022 May 14.
9
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.
JAMA Oncol. 2020 Jul 1;6(7):1003-1010. doi: 10.1001/jamaoncol.2020.1024.
10
Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives.
Cancers (Basel). 2020 Mar 22;12(3):751. doi: 10.3390/cancers12030751.
Zotero 插件